People fixate over these tiny things, little differences in the arrangement of deck chairs, as they are dying of a medical condition called aging, that might be controlled and prevented entirely if enough of them stopped fixating on tiny things and started helping to fund rejuvenation therapies.
There are startup companies now, today, working on the first rejuvenation treatments that address one of the actual root causes of aging. Oisin Biotechnologies and UNITY Biotechnology. Look them up, look up the senescent cell clearance methodologies they are turning from labwork to clinical treatment. These therapies will not cost very much when ready, simple mass-produced infusions.
Yet what is in the news and the thing that people pay attention to? Tiny differences in the status quo, who has a better deck chair as the ship is going down.
It is a frustrating thing to be living in the human condition.
Among the less attractive aspects of human nature are a fixation with what is rather than what can be, the tendency to limit the definition of success and desired outcomes to whatever the best of the present options might be, and a burning desire to tear down those who have more than you rather than work to create more for everyone. Even in an age of rapid, radical change driven by advancing technology, the vast majority of people focus entirely on the distribution of present assets and opportunities, giving little to no thought to the much larger set of assets and opportunities that we could create for tomorrow.
You see this in the vastly greater attention given to any evidence for distributions and correlations in life expectancy between populations today, and the tiny amount of attention and support given to the production of rejuvenation therapies to greatly increase life for everyone at a modest cost. Given the realization of SENS rejuvenation treatments, the first of which are already under development in startup companies, and most of which will take the form of comparatively low-cost, mass-produced infusions, ten year variations in longevity due to lifestyle choices or access to medicine will be swamped, made irrelevant and small.
There are startup companies now, today, working on the first rejuvenation treatments that address one of the actual root causes of aging. Oisin Biotechnologies and UNITY Biotechnology. Look them up, look up the senescent cell clearance methodologies they are turning from labwork to clinical treatment. These therapies will not cost very much when ready, simple mass-produced infusions.
Yet what is in the news and the thing that people pay attention to? Tiny differences in the status quo, who has a better deck chair as the ship is going down.
It is a frustrating thing to be living in the human condition.